Management of Chronic Myeloid Leukemia

Management of Chronic Myeloid Leukemia

Episodes

Specialty:

All

Year:

All

EP. 1: An Overview of Chronic Myeloid Leukemia

August 15th 2018

EP. 2: RT PCR Testing in CML: Finding BCR-ABL TKI Candidates

August 15th 2018

EP. 3: CML: Frontline BCR-ABL TKI Therapy

August 15th 2018

EP. 4: CML: Factors in Selecting a BCR-ABL TKI

August 15th 2018

EP. 5: When to Switch Therapy in Chronic Myeloid Leukemia

August 15th 2018

EP. 6: TIDEL-II: Switching From Imatinib to Nilotinib in CML

August 15th 2018

EP. 7: CML: Considering Second-Generation TKIs

August 15th 2018

EP. 8: Optimizing the Use of BCR-ABL TKIs in CML

August 15th 2018

EP. 9: Chronic Myeloid Leukemia: Understanding Loss of Response

August 15th 2018

EP. 10: CML: Improving Treatment for Patients Who Don't Respond

August 15th 2018

EP. 11: Achieving Treatment-Free Remissions in CML

August 15th 2018

EP. 12: Chronic Myeloid Leukemia: Selecting Patients for TFR

August 15th 2018

EP. 13: TFR With Nilotinib in CML: ENESTfreedom and ENESTop

August 15th 2018

EP. 14: Unmet Needs and Future Directions in CML

August 15th 2018

Trending on OncLive

VOLGA, DASL-HiCaP Data Highlight Key Genitourinary Cancer Presentations Arriving at ESMO 2026

Stay Ahead of ESMO 2026: See What Lung Cancer Experts Are Prioritizing

The OncFive: Top Oncology Articles for the Week of 10/11

CHMP Recommends Approval of Daraxonrasib for Previously Treated Metastatic Pancreatic Cancer

Dr Berdeja on the Potential Role of CELMoDs in Multiple Myeloma Management